Ryan & Maniskas, LLP Announces Investigation of Patient Safety Technologies, Inc.
WAYNE, Pa., Jan. 9, 2014 /PRNewswire/ -- Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Patient Safety Technologies, Inc. ("Patient Safety" or the "Company") (OTC: PSTX) concerning possible breaches of fiduciary duty and other violations of law related to the Company's entry into an agreement to be acquired by Stryker Corporation in a transaction valued at approximately $120 million.
If you own shares of Patient Safety and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/pstx. You may also email Mr. Maniskas at firstname.lastname@example.org.
Under the terms of the agreement, public shareholders of Patient Safety will receive $2.22 per share in cash for each share of Patient Safety they own.
Our investigation concerns possible breaches of fiduciary duty and other violations of state law by Patient Safety's Board of Directors for not acting in the Company's shareholders' best interests in connection with the sale process.
Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide. To learn more about the class action process, please visit: www.rmclasslaw.com.
SOURCE Ryan & Maniskas, LLP
More by this Source
Ryan & Maniskas, LLP Announces Investigation of Cbeyond, Inc.
Apr 23, 2014, 09:55 ET
Ryan & Maniskas, LLP Announces Investigation of FedFirst Financial Corp.
Apr 21, 2014, 10:35 ET
Ryan & Maniskas, LLP Announces Investigation of Zygo Corporation
Apr 14, 2014, 10:58 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.